SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-23-031910
Filing Date
2023-07-06
Accepted
2023-07-06 09:24:40
Documents
11

Document Format Files

Seq Description Document Type Size
1 DEFA14A itrm_defa14a_presentatio.htm DEFA14A 49121
2 GRAPHIC img176931358_0.jpg GRAPHIC 280837
3 GRAPHIC img176931358_1.jpg GRAPHIC 1522043
4 GRAPHIC img176931358_2.jpg GRAPHIC 994697
5 GRAPHIC img176931358_3.jpg GRAPHIC 537915
6 GRAPHIC img176931358_4.jpg GRAPHIC 728535
7 GRAPHIC img176931358_5.jpg GRAPHIC 1010436
8 GRAPHIC img176931358_6.jpg GRAPHIC 1246336
9 GRAPHIC img176931358_7.jpg GRAPHIC 1139710
10 GRAPHIC img176931358_8.jpg GRAPHIC 681556
11 GRAPHIC img176931358_9.jpg GRAPHIC 161989
  Complete submission text file 0000950170-23-031910.txt   11488132
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38503 | Film No.: 231072248
SIC: 2834 Pharmaceutical Preparations